A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom – (A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom, Published online: 2018-12-28; | doi:10.1038/s41433-018-0217-x)
A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom, Published online: 28 December 2018; doi:10.1038/s41433-018-0217-x A prospective study of the incidence, associations and outcomes of ocular surface squamous
Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis – (Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis, Published online: 2018-12-21; | doi:10.1038/s41433-018-0321-y)
Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis, Published online: 21 December 2018; doi:10.1038/s41433-018-0321-y Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in
Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day – (Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day, Published online: 2018-12-19; | doi:10.1038/s41433-018-0320-z)
Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day, Published online: 19 December 2018; doi:10.1038/s41433-018-0320-z Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day
Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks – (Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks, Published online: 2018-12-19; | doi:10.1038/s41433-018-0312-z)
Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks, Published online: 19 December 2018; doi:10.1038/s41433-018-0312-z Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary
The Royal College of Ophthalmologists introduces electronic exams
The RCOphth (The Royal College of Ophthalmologists) examinations department will be going through a period of exciting and momentous change in 2019 as the vast majority of exams become fully electronic to adapt to and embrace advances in examination technology as well as creating a model for complete paperless examinations. Ripley Systems are the provider